Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Interojo Inc. (119610.KQ)
KRW15,580.00
+660.00 (+4.42%)
KR KOE Healthcare Medical - Instruments & Supplies
Address
28&25 Sandan-ro 13486
Pyeongtaek-si, GG, KR
Pyeongtaek-si, GG, KR
CEO
Dong-chul Kim
Website
interojo.com
IPO
2010-07-28
ISIN KR7119610004
Description
Interojo Inc. manufactures and sells contact lenses in South Korea and internationally. It offers silicone hydrogel lens, premium hydrogel lens, hydrogel lens, color lens, RGP, and other products. The company was founded in 2000 and is headquartered in Pyeongtaek-si, South Korea.
Market Cap & Enterprise Value
Merger & Acquisition History
No mergers or acquisitions recorded for this company.
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
KRW15,580.00
+660.00 (+4.42%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
93.7K
Beta
0.33
Float Shares
7.02M
Free Float %
61.5%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -3.19% | -8.42% | -4.16% | +5.75% | +17.42% | +18.44% | -23.13% | -48.48% | -16.92% | -50.04% | +373.04% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Price Targets & DCF
Current price
15,580.00
DCF (Unlevered)
59,070.20
+279.1%
DCF (Levered)
129,273.66
+729.7%
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
Ratings Trend (MoM)
100% Bullish
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 1 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
Quality scores
Altman Z-Score
3.40
Safe zone
Piotroski F-Score
5 / 9
Average
MOAT Score
4 / 10
Developing
Composite Rating
B+
Overall Score
3 / 5
Medium
DCF Score
2 / 5
Medium
ROE Score
3 / 5
Medium
ROA Score
4 / 5
High
D/E Score
2 / 5
Medium
P/E Score
3 / 5
Medium
P/Book Score
4 / 5
High
Operational MOAT
✗ Below peers
-
Revenue growth Medical - Instruments & Supplies: +7.9%+2.3% Q1'26: +32.8% (vs Q1'25)
-
EPS growth Medical - Instruments & Supplies: +16.3%+7,643.8% ★ Q1'26: +286.1% (vs Q1'25)
-
FCF margin FCF growth · Medical - Instruments & Supplies: +27.1%+17.9% ★ Q1'26: +16.9% (vs Q1'25)
-
EBIT margin Medical - Instruments & Supplies: +13.5%+16.4% ★ Q1'26: +20.3% (vs Q1'25)
-
ROIC Medical - Instruments & Supplies: +6.0%+9.1% ★ Q1'26: +10.6% (vs Q1'25)
-
Share dilution Medical - Instruments & Supplies: +0.1%-8.9% ★ Q1'26: -8.9% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Medical - Instruments & Supplies: -0.24×1.89× Q1'26: 2.23× (vs Q1'25)
Valuation Multiples
From
To
Price Forecast (3Y)
From
To
Theoretical Return — If Invested Today
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
Consensus Estimates
| Metric |
Dec 2015 actual |
Dec 2016 actual |
Dec 2017 actual |
Dec 2018 actual |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 3 Rev. Ana. 2 EPS Ana. |
Dec 2027 3 Rev. Ana. 2 EPS Ana. |
Dec 2028 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
59.56B
est: 59.62B (-0.1%)
|
73.71B
est: 73.05B (+0.9%)
|
80.62B
est: 82.96B (-2.8%)
|
79.43B
est: 79.17B (+0.3%)
|
92.57B
est: 92.60B (0.0%)
|
88.20B
est: 88.20B (+0.0%)
|
107.53B
est: 118.70B (-9.4%)
|
117.82B
est: 128.00B (-8.0%)
|
119.30B
est: 147.50B (-19.1%)
|
115.84B
est: 170.20B (-31.9%)
|
118.53B
est: 197.00B (-39.8%)
|
143.40B
141.20B – 145.20B
-27.2% YoY
|
165.50B
162.53B – 169.62B
+15.4% YoY
|
188.80B
185.64B – 192.41B
+14.1% YoY
|
| EBITDA |
20.03B
est: 15.27B (+31.2%)
|
27.51B
est: 18.71B (+47.1%)
|
28.73B
est: 21.24B (+35.2%)
|
21.99B
est: 20.27B (+8.4%)
|
29.34B
est: 23.71B (+23.7%)
|
23.51B
est: 22.59B (+4.1%)
|
30.81B
est: 30.40B (+1.4%)
|
39.10B
est: 32.78B (+19.3%)
|
28.78B
est: 37.77B (-23.8%)
|
15.22B
est: 42.19B (-63.9%)
|
29.45B
est: 48.83B (-39.7%)
|
35.55B
35.00B – 35.99B
-27.2% YoY
|
41.03B
40.29B – 42.05B
+15.4% YoY
|
46.80B
46.02B – 47.70B
+14.1% YoY
|
| EBIT |
15.69B
est: 10.40B (+50.9%)
|
24.09B
est: 12.74B (+89.0%)
|
24.22B
est: 14.47B (+67.3%)
|
18.04B
est: 13.81B (+30.6%)
|
22.88B
est: 16.15B (+41.6%)
|
15.80B
est: 15.39B (+2.7%)
|
22.18B
est: 20.71B (+7.1%)
|
29.85B
est: 22.33B (+33.7%)
|
5.19B
est: 25.73B (-79.8%)
|
5.02B
est: 28.15B (-82.2%)
|
19.47B
est: 32.59B (-40.2%)
|
23.72B
23.36B – 24.02B
-27.2% YoY
|
27.38B
26.89B – 28.06B
+15.4% YoY
|
31.23B
30.71B – 31.83B
+14.1% YoY
|
| Net Income |
12.59B
est: 12.45B (+1.1%)
|
19.35B
est: 20.08B (-3.6%)
|
19.27B
est: 20.96B (-8.0%)
|
14.60B
est: 15.50B (-5.8%)
|
17.56B
est: 19.37B (-9.4%)
|
11.54B
est: 11.69B (-1.2%)
|
14.74B
est: 18.40B (-19.9%)
|
18.64B
est: 22.22B (-16.1%)
|
3.16B
est: 28.29B (-88.8%)
|
184.34M
est: 35.76B (-99.5%)
|
13.00B
est: 41.76B (-68.9%)
|
19.31B
18.43B – 20.19B
-53.8% YoY
|
24.21B
23.25B – 25.17B
+25.4% YoY
|
29.12B
28.48B – 29.84B
+20.3% YoY
|
| SGA |
9.31B
est: 9.55B (-2.5%)
|
11.37B
est: 11.70B (-2.8%)
|
11.87B
est: 13.29B (-10.6%)
|
12.52B
est: 12.68B (-1.3%)
|
12.87B
est: 14.83B (-13.2%)
|
18.54B
est: 14.13B (+31.3%)
|
22.22B
est: 19.01B (+16.9%)
|
22.50B
est: 20.50B (+9.8%)
|
13.53B
est: 23.62B (-42.7%)
|
12.53B
est: 24.37B (-48.6%)
|
11.48B
est: 28.21B (-59.3%)
|
20.53B
20.22B – 20.79B
-27.2% YoY
|
23.70B
23.27B – 24.29B
+15.4% YoY
|
27.04B
26.58B – 27.55B
+14.1% YoY
|
| EPS |
1,033.18
est: 993.66 (+4.0%)
|
1,584.87
est: 1,602.45 (-1.1%)
|
1,594.99
est: 1,672.58 (-4.6%)
|
1,232.75
est: 1,236.66 (-0.3%)
|
1,458.38
est: 1,546.26 (-5.7%)
|
978.65
est: 932.84 (+4.9%)
|
1,206.00
est: 1,468.63 (-17.9%)
|
1,472.00
est: 1,773.25 (-17.0%)
|
253.00
est: 2,258.00 (-88.8%)
|
14.71
est: 3,133.00 (-99.5%)
|
1,139.11
est: 3,659.00 (-68.9%)
|
1,692.00
1,614.79 – 1,769.21
-53.8% YoY
|
2,121.00
2,036.55 – 2,205.45
+25.4% YoY
|
2,551.00
2,495.50 – 2,614.43
+20.3% YoY
|
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-08 | B+ | 3/5 | 2/5 | 3/5 | 4/5 | 2/5 | 3/5 | 4/5 |
| 2026-05-07 | B+ | 3/5 | 2/5 | 3/5 | 4/5 | 2/5 | 3/5 | 4/5 |
| 2026-05-06 | B+ | 3/5 | 2/5 | 3/5 | 4/5 | 2/5 | 3/5 | 4/5 |
| 2026-05-04 | B+ | 3/5 | 2/5 | 3/5 | 4/5 | 2/5 | 3/5 | 4/5 |
| 2026-04-30 | B | 3/5 | 2/5 | 3/5 | 4/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-29 | B+ | 3/5 | 2/5 | 3/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-28 | B+ | 3/5 | 2/5 | 3/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-27 | B+ | 3/5 | 2/5 | 3/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-24 | B+ | 3/5 | 2/5 | 3/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-23 | B+ | 3/5 | 3/5 | 3/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-22 | B+ | 3/5 | 3/5 | 3/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-21 | B+ | 3/5 | 3/5 | 3/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-20 | B+ | 3/5 | 3/5 | 3/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-17 | B+ | 3/5 | 3/5 | 3/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-16 | B+ | 3/5 | 3/5 | 3/5 | 5/5 | 1/5 | 3/5 | 4/5 |
Owner Earnings
Owner's Earnings (history)
From
To
Owner alignment
Owner's Earnings TTM
25.08B
OE per share TTM
2,108.70
Owner's Yield
10.66%
Maintenance CapEx ratio
95.28%
Maint CapEx / Avg PPE
74.9%
Ownership Overview
Ownership breakdown
Ownership breakdown not available.
At a glance
Institutional holders
—
Total invested
—
Insider transactions (90d)
0
Beneficial owners (>5%)
0
Beneficial owners (>5%)
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional ownership trend
Institutional history not available.
Top institutional holders
Top holders not available.
ETF Ownership
Top ETFs holding this stock
Held by 3 ETFs in our universe
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | Dimensional - Emerging Markets Value ETF DFEV | 0.00% | 9.0K | 0.46% |
| 2 | Dimensional - Emerging Markets Core Equity 2 ETF DFEM | 0.00% | 31.9K | 0.39% |
| 3 | Dimensional - Emerging Core Equity Market ETF DFAE | 0.00% | 16.3K | 0.29% |
Insider Activity
Insider Activity — Latest Quarter
No insider activity available.
Insider buys vs sells (history)
Insider history not available.
Recent insider transactions
No recent insider transactions.
Executive team
Top executives
EBIT / Employee
128.96M
Shares Outstanding
11.41M
Executive compensation
Executive compensation (annual)
Executive compensation not available.
CEO compensation breakdown
No CEO compensation history available.
Proxy statements
Proxy statements (DEF 14A)
No proxy statements available for this company yet.
Recent SEC filings
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Si-Cheol Roh | CEO & Chairman | — | male |
ESG Score History
No data available for this company.
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
No House trading activity found for this company.
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 119610.KQ
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
